Department of Medical Statistics, Sun Yat-sen University, Guangzhou, Guangdong, PR China.
Hospital of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong, PR China.
Drug Alcohol Depend. 2022 Sep 1;238:109581. doi: 10.1016/j.drugalcdep.2022.109581. Epub 2022 Jul 21.
Half of methadone maintenance treatment (MMT) participants experience a tapering phase, however, the guidelines vary from country to country and lack individualized strategies based on relapse risk. A detailed and individualized tapering strategy is needed in China. This study aims to explore dose tapering strategies for Chinese individuals with different relapse risks.
A retrospective study was conducted from 2006 to 2017 at nine MMT clinics in Guangdong, China, involving 549 participants. The end point was the first relapse within 12 months of the start of tapering. Relapse risks before tapering for each participant were determined from a Cox model.
Out of 549 participants, 173 (31.5 %) relapsed within 12 months after tapering. Findings indicated that a taper dose of less than 5 mg/week is better than other taper doses. Subpopulation treatment effect pattern plot (STEPP) methodology revealed different tapering strategies benefit participants according to relapse risk before tapering. Overall, findings indicated that a less than 5 mg/week reduction in MMT dose is better than reductions of other amounts. For participants with a low relapse risk before tapering, a reduction of less than 2.5 mg/week in MMT dose is better than a 2.5-5 mg/week reduction.
A taper dose of less than 5 mg/week appears to be the best dose tapering strategy for Chinese participants. Furthermore, for participants with a low relapse risk, a more gradual taper dose (less than 2.5 mg/week) works better than 2.5-5 mg/week. This benefit was not seen in participants with a high relapse risk before tapering.
半数美沙酮维持治疗(MMT)参与者经历了逐渐减少剂量的阶段,但各国的指南不同,缺乏基于复发风险的个体化策略。中国需要一种详细和个体化的逐渐减少剂量策略。本研究旨在探索针对中国不同复发风险个体的剂量减少策略。
本研究为 2006 年至 2017 年期间在中国广东省的 9 个 MMT 诊所进行的回顾性研究,共纳入 549 名参与者。终点是逐渐减少剂量开始后 12 个月内的首次复发。每个参与者逐渐减少剂量前的复发风险通过 Cox 模型确定。
在 549 名参与者中,有 173 名(31.5%)在逐渐减少剂量后 12 个月内复发。研究结果表明,每周减少剂量小于 5mg 优于其他减少剂量。亚人群治疗效果模式图(STEPP)方法表明,根据逐渐减少剂量前的复发风险,不同的逐渐减少剂量策略对参与者有益。总体而言,结果表明 MMT 剂量减少小于 5mg/周优于减少其他剂量。对于逐渐减少剂量前复发风险较低的参与者,减少 MMT 剂量小于 2.5mg/周优于减少 2.5-5mg/周。
每周减少剂量小于 5mg 似乎是中国参与者的最佳剂量减少策略。此外,对于复发风险较低的参与者,逐渐减少剂量(小于 2.5mg/周)比 2.5-5mg/周更有效。在逐渐减少剂量前复发风险较高的参与者中未观察到这种益处。